HIV Ischemic Heart Disease
Conditions
Interventions
Sponsors
National Center for Global Health and Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: (1) Individuals who have given written consent to participate in the research. (2) Males and females aged 20 years or older at the time of obtaining consent (3) Those with a positive anti-HIV antibody test result.
Exclusion criteria
Exclusion criteria: (1) Patients who have been diagnosed with ischemic heart disease (2) Patients who have been diagnosed with hemophilia (3) Patients with a history of hypersensitivity to iodine or iodine contrast media (4) Persons with serious thyroid disease (5) Patients with severe bronchial asthma 6) Patients with severe cardiac disorders 7) Patients with severe hepatic impairment 8) Patients with severe renal dysfunction 9) Patients with macroglobulinemia 10) Patients with multiple myeloma 11) Patients with tetany 12) Patients with pheochromocytoma or suspected pheochromocytoma 13) Patients of childbearing potential 14) Those who are judged by the principal investigator to be inappropriate for inclusion in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Prevalence of Ischemic Heart Disease in Non-Hemophilic HIV-Infected Patients | — |
Secondary
| Measure | Time frame |
|---|---|
| Evaluation for correlation between risk factors for ischemic heart disease and ischemic heart disease in non-hemophilia HIV-infected patients and usefulness of screening test | — |
Countries
Japan
Contacts
Public ContactYukio Hiroi
National Center for Global Health and Medicine Cardiology
Outcome results
None listed